You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: April 1, 2025

Details for Patent: RE39221


✉ Email this page to a colleague

« Back to Dashboard


Summary for Patent: RE39221
Title:Composition comprising a tramadol material and acetaminophen and its use
Abstract:This invention relates to a composition comprising a tramadol material and acetaminophen, and its use. As used herein tramadol refers to various forms of tramadol. The compositions are pharmacologically useful in treating pain and tussive conditions. The compositions are also subject to less opioid side-effects such as abuse liability, tolerance, constipation and respiratory depression. Furthermore, where the components of the compositions are within certain ratios the pharmacological effects of the compositions are superadditive (synergistic).
Inventor(s): Raffa; Robert B. (Norristown, PA), Vaught; Jeffrey L. (Glenmoore, PA)
Assignee: Ortho-McNeil Pharmaceutical, Inc. (Raritan, NJ)
Application Number:10/761,096
Patent Claim Types:
see list of patent claims
Composition; Use; Dosage form; Formulation;
Patent landscape, scope, and claims:

Detailed Analysis of the Scope and Claims of United States Patent RE39221

Introduction

When analyzing the scope and claims of a patent, such as United States Patent RE39221, it is crucial to understand the patent's context, the technology it covers, and the legal framework surrounding it. Here, we will delve into the key aspects of patent scope, claims, and the broader patent landscape.

Understanding Patent Scope

Patent scope is a critical aspect of patent law, as it defines the boundaries of what is protected by the patent. The scope is largely determined by the claims section of the patent, which outlines the specific features and limitations of the invention[3].

Claim Language and Structure

The claims section of a patent is where the inventor or patent holder defines what is novel and non-obvious about their invention. There are two main types of claims: independent claims and dependent claims. Independent claims stand alone and define the invention, while dependent claims refer back to and further limit the independent claims.

  • Independent Claim Length and Count: Research has shown that the length and number of independent claims can be metrics for measuring patent scope. Patents with narrower claims, as indicated by shorter independent claim lengths and fewer independent claims, tend to have a higher probability of grant and a shorter examination process[3].

Patent Claims Analysis for RE39221

To analyze the scope of RE39221, one would need to examine the specific claims made in the patent.

  • Claim Construction: The claims must be construed to understand their meaning and scope. This involves interpreting the language of the claims in the context of the specification and any relevant prior art. The Federal Circuit has emphasized that claim construction should be done on a claim-by-claim basis, ensuring that the claims inform those skilled in the field with reasonable certainty[2].

  • Mutual Exclusivity: Claims should not be mutually exclusive, meaning they should not describe the same invention in ways that are inconsistent. The court in the case of Vascular Solutions LLC v. Medtronic, Inc. highlighted the importance of consistent claim construction across all asserted patents[2].

Patent Examination Process

The examination process plays a significant role in shaping the scope of a patent.

  • Office Actions: During the examination process, the patent office may issue office actions, which are documents written by patent examiners that outline issues with the patent application. These actions can lead to the narrowing of claims to overcome prior art or other objections[1].

  • Expedited Examination: For patents in rapidly evolving fields, expedited examination options such as Accelerated Examination or Track One Prioritized Examination can be used to reduce the examination time to approximately 12 months. This can be crucial for maintaining the relevance and competitiveness of the invention[1].

Patent Landscape and Prior Art

Understanding the broader patent landscape is essential for assessing the validity and scope of a patent.

  • Prior Art Search: Conducting a thorough prior art search is critical in preparing a patent application. This search helps in identifying existing inventions that may affect the novelty and non-obviousness of the claimed invention. The USPTO provides tools such as the Global Dossier and the Common Citation Document (CCD) to facilitate this process[4].

  • Global Dossier and CCD: These tools allow users to access file histories of related applications from participating IP offices and consolidate prior art citations, making it easier to assess the global patent landscape for a particular invention[4].

Legal Framework and Amendments

The legal framework governing patents, including amendments and corrections, is outlined in the U.S. Code.

  • Reissue Patents: A reissue patent cannot enlarge the scope of the original patent's claims unless applied for within two years from the grant of the original patent. This ensures that the original scope of protection is not expanded retroactively[5].

Case Law and Precedents

Case law and judicial precedents play a significant role in interpreting patent claims and scope.

  • Claim Indefiniteness: The case of Vascular Solutions LLC v. Medtronic, Inc. highlights the importance of clear and definite claim language. Claims that are deemed indefinite can lead to the invalidation of the patent[2].

Economic and Strategic Implications

The scope and claims of a patent have significant economic and strategic implications.

  • Licensing and Litigation: Broad or unclear claims can lead to increased licensing and litigation costs, potentially diminishing incentives for innovation. Narrower, well-defined claims can mitigate these risks[3].

  • Maintenance Costs: The total investment to prepare, prosecute, and maintain a patent over its life can be substantial, often exceeding $200,000 for international filings. Clear and focused claims can help in managing these costs[1].

Key Takeaways

  • Patent Scope: Defined by the claims section, patent scope is crucial for understanding what is protected by the patent.
  • Claim Construction: Claims must be construed on a claim-by-claim basis to ensure clarity and consistency.
  • Examination Process: The examination process, including office actions and expedited options, shapes the final scope of the patent.
  • Prior Art: Thorough prior art searches are essential for ensuring the novelty and non-obviousness of the invention.
  • Legal Framework: Amendments and corrections to patents are governed by specific legal provisions to maintain the integrity of the original patent.

FAQs

Q: What is the primary factor in determining the scope of a patent? A: The primary factor is the claims section of the patent, which outlines the specific features and limitations of the invention.

Q: How can the scope of a patent be narrowed during the examination process? A: The scope can be narrowed through office actions and the applicant's responses, which may involve amending the claims to overcome prior art or other objections.

Q: What are the benefits of using expedited examination options for patent applications? A: Expedited options like Track One Prioritized Examination can reduce the examination time to approximately 12 months, which is beneficial in rapidly evolving technological fields.

Q: How does the Global Dossier help in patent searches? A: The Global Dossier provides access to file histories of related applications from participating IP offices and consolidates prior art citations, facilitating a comprehensive search of the global patent landscape.

Q: Can a reissue patent enlarge the scope of the original patent's claims? A: No, a reissue patent cannot enlarge the scope of the original patent's claims unless applied for within two years from the grant of the original patent.

Sources

  1. TIMELINE AND COSTS FOR PATENT FILINGS - SBIR
  2. VASCULAR SOLUTIONS LLC v. MEDTRONIC, INC. - CAFC
  3. Patent Claims and Patent Scope - SSRN
  4. Search for patents - USPTO
  5. 35 USC Ch. 25: AMENDMENT AND CORRECTION OF PATENTS - US Code

More… ↓

⤷  Try for Free


Drugs Protected by US Patent RE39221

ApplicantTradenameGeneric NameDosageNDAApproval DateTETypeRLDRSPatent No.Patent ExpirationProductSubstanceDelist Req.Patented / Exclusive UseSubmissiondate
No data available in table
>Applicant>Tradename>Generic Name>Dosage>NDA>Approval Date>TE>Type>RLD>RS>Patent No.>Patent Expiration>Product>Substance>Delist Req.>Patented / Exclusive Use>Submissiondate
Showing 0 to 0 of 0 entries

International Family Members for US Patent RE39221

CountryPatent NumberEstimated ExpirationSupplementary Protection CertificateSPC CountrySPC Expiration
Austria 169498 ⤷  Try for Free
European Patent Office 0566709 ⤷  Try for Free 91079 Luxembourg ⤷  Try for Free
European Patent Office 0566709 ⤷  Try for Free SPC/GB04/012 United Kingdom ⤷  Try for Free
European Patent Office 0566709 ⤷  Try for Free 300152 Netherlands ⤷  Try for Free
European Patent Office 0566709 ⤷  Try for Free SPC023/2008 Ireland ⤷  Try for Free
European Patent Office 0566709 ⤷  Try for Free C300152 Netherlands ⤷  Try for Free
>Country>Patent Number>Estimated Expiration>Supplementary Protection Certificate>SPC Country>SPC Expiration
Showing 1 to 6 of 6 entries

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.